| Literature DB >> 35335611 |
Chao Lv1,2, Wangping Deng1, Liping Wang3, Zhiqiang Qin1, Xiaonong Zhou1,2, Jing Xu1.
Abstract
Schistosomiasis japonica caused by the trematode flukes of Schistosoma japonicum was one of the most grievous infectious diseases in China in the mid-20th century, while its elimination has been placed on the agenda of the national strategic plan of healthy China 2030 after 70 years of continuous control campaigns. Diagnostic tools play a pivotal role in warfare against schistosomiasis but must adapt to the endemic status and objectives of activities. With the decrease of prevalence and infection intensity of schistosomiasis in human beings and livestock, optimal methodologies with high sensitivity and absolute specificity are needed for the detection of asymptomatic cases or light infections, as well as disease surveillance to verify elimination. In comparison with the parasitological methods with relatively low sensitivity and serological techniques lacking specificity, which both had been widely used in previous control stages, the molecular detection methods based on the amplification of promising genes of the schistosome genome may pick up the baton to assist the eventual aim of elimination. In this article, we reviewed the developed molecular methods for detecting S. japonicum infection and their application in schistosomiasis japonica diagnosis. Concurrently, we also analyzed the chances and challenges of molecular tools to the field application process in China.Entities:
Keywords: diagnostic tools; elimination; molecular techniques; schistosomiasis japonica
Year: 2022 PMID: 35335611 PMCID: PMC8951378 DOI: 10.3390/pathogens11030287
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1The molecular diagnostic techniques of schistosomiasis japonica and the year of first report in China. 1 nPCR is characterized by two pairs of primers, inner primer and outer primer; 2 qPCR can quantitatively and qualitatively analyze the initial template of samples by detecting the fluorescence signal corresponding to each cyclic amplification product in real time; 3 The combination of RPA and lateral flow dipstick (LFD) for visual detection. Generally, visualization of control line and the test line is positive, and only the control line is negative; 4 cPCR determined positive or negative results by the size of the gel electrophoresis band; 5 The combination of LAMP reaction with chemical dyes for visual detection. + positive reaction, − negative reaction; 6 Dilute sample or samples DNA to the single molecule level and collect the fluorescence signal of a single reaction unit to achieve the absolute quantitative detection. Black spots: positive reaction units, blank spots: negative reaction units.
The target genes and sample types of established cPCR methods for schistosomiasis japonica.
| Target Sequence | No. of GenBank Accession | Fragment Size (bp) | Detection Limit | Specimen | Year of Publication | |
|---|---|---|---|---|---|---|
| 1 | Sj5D | N/D 1 | 262 | 1 cercarial; | Animal tissue and blood | 1997,1998 [ |
| 2 | Sj5D | N/D | 262 | 10 fold diluted single cercarial DNA | Cercarial DNA | 2004 [ |
| 3 | 18S rRNA | DQ442999 | 469 | 40 pg | gDNA | 2006 [ |
| 4 | 18S rRNA | DQ442999 | 469 | 1 cercaria | Cercaria | 2008 [ |
| 5 | 18S rRNA | DQ442999 | 463 | 62.5 pg | gDNA | 2010 [ |
| 6 | 18S rRNA | FJ176682 | 157 | 1 cercaria in pooled 10 non-infected snails; | Snail; | 2013 [ |
| 7 | 28S rRNA | Z46504 | 405 | 100 fg | gDNA | 2010 [ |
| 8 | 28S rRNA | Z46504 | 607 | 15 pg | gDNA | 2006 [ |
| 9 | 28S rRNA | Z46504 | 200 | N/D | Cattle fecal | 2017 [ |
| 10 | 28S rRNA | EU835689.1 | 330 | N/D | Snail | 2018 [ |
| 11 | COX1 | AF215860 | 614 | 10fg | gDNA | 2010 [ |
| 12 | COX1 | AF215860 | 254 | N/D | Serum and urine | 2015 [ |
| 13 | SjR2 | AF412221 | 230 | 1 pg | gDNA | 2010 [ |
| 14 | SjR2 | AF412221 | 230 | 0.8 pg | gDNA | 2009 [ |
| 15 | SjR2 | N/D | 176 | 1 cercariae | Cercariae | 2005 [ |
| 16 | SjR2 | AF412221 | 230 | 0.021 eggs | Egg DNA | 2007 [ |
| 17 | SjR2 | AF412221 | 230 | 0.5 eggs/g of feces | Human feces | 2012 [ |
| 18 | SjR2 | N/D | 408 | 1 egg | Colon tissue | 2019 [ |
| 19 | Mitochondrial DNA gene | N/A 2 | 668/242 | 0.3 eggs | Fecal of mice | 2005 [ |
1 N/D: Non-disclosed; 2 N/A: Non-applicable.
The target genes and application performance of qPCR assay for schistosomiasis japonica.
| Target Sequence | No. of GenBank Accession | Fragment Size (bp) | Detection Limit | Sensitivity (%) | Specificity (%) | Prevalence 1 | Specimen | Year of Publication | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NADH I | N/D 2 | 82 | 1 EPG | N/A 3 | N/A | N/A | Human feces | 2006 [ |
| 2 | NADH I | N/D | 75 | 1 EPG | N/A | N/A | 5.3% | Human feces | 2009 [ |
| 3 | NADH I | N/D | 82 | 5 EPG | 100/96.83 | 100 | 11.06% of human; 24.73% of bovines | Buffalo and human feces | 2018 [ |
| 4 | NADH I | N/D | 82 | 1 EPG | 100 | 100 | 51.5% | Buffalo feces | 2010 [ |
| 5 | NADH I | N/D | 82 | one egg; 14 pg | 95.25/94.0 | 100 | 95.45% | buffalo and Human feces; | 2012 [ |
| 6 | NADH I | N/D | 82 | N/A | N/A | N/A | 87.50% | Bovines feces | 2015 [ |
| 7 | NADH I | N/D | 82 | N/A | N/A | N/A | 90.2% | Human feces | 2015 [ |
| 8 | NADH I | N/D | 82 | N/A | N/A | N/A | N/A | Serum, urine and fecal of pig model | 2008 [ |
| 9 | NADH I | N/D | 82 | 5 EPG | N/A | N/A | N/A | Buffalo feces | 2009 [ |
| 10 | NADH I | N/D | 82 | N/A | N/A | N/A | 9.21% of rodents; 18.37% of dogs; 6.9% of goats | Rodents, dogs and goats feces | 2017 [ |
| 11 | NADH I | AF215860 | 75 | N/A | N/A | N/A | N/A | Organs | 2018 [ |
| 12 | COX I | N/D | 119 | N/A | N/A | N/A | N/A | Water samples | 2019 [ |
| 13 | 18S rRNA | AYl57226 | 81 | 6.15 pg | N/A | N/A | 48.0% | gDNA | 2008 [ |
| 14 | 18S rRNA | AY157226 | 81 | 10 fg | N/A | N/A | N/A | gDNA | 2011 [ |
| 15 | 18S rRNA | AY157226.1 | N/D | 20 fg | N/A | N/A | N/A | gDNA | 2011 [ |
| 16 | 18S rRNA | FJ176682 | 156 | 4.3 × 102 copies plasmid; 0.4 fg gDNA; 10 EPG; one cercaria in 10 pooled snails; | N/A | N/A | N/A | Plasmids; gDNA; mice feces; snail | 2013 [ |
| 17 | 18S rRNA | AY157226 | 280 | 10 fg | N/A | N/A | N/A | gDNA | 2015 [ |
| 18 | ITS 2 | U22167 | 192 | 1.42 × 102 copies plasmid; 10 pg gDNA; 10 EPG; | 100 | 100 | N/A | Snail and mice feces | 2011 [ |
| 19 | SjR2 | AF412221.1 | N/D | 2 pg | N/A | N/A | N/A | gDNA | 2011 [ |
| 20 | SjR2 | AF412221 | N/D | 44.7 copies plasmid | N/A | N/A | N/A | Plasmids and sera of rabbit | 2014 [ |
| 21 | SjR2 | N/D | N/D | N/A | N/A | N/A | N/A | Water samples | 2021 [ |
| 22 | SjCHGCS20 | FN356222.1 | N/D | N/D | 98.74 | 100 | 8.33 | Plasma of goat | 2020 [ |
| 23 | SjCHGC08270 | AY812553 | 85 | half of one cercaria | 93.75 | N/D | N/A | N/A | 2008 [ |
| 24 | SjCHGC08270 | AY812553 | 85 | one cercaria | N/A | N/A | 6.48 | Water samples | 2011 [ |
| 25 | Sjrh1.0 | U92488.1 | N/D | 2 fg | N/A | N/A | N/A | gDNA and sera of mice | 2011 [ |
| 26 | Sjrh1.0 | U92488.1 | N/D | 2 fg | N/A | N/A | N/A | gDNA and water samples | 2011 [ |
1 Prevalence: no. positive/no. examined; 2 N/D: Non-disclosed; 3 N/A: Non-applicable.
Advantages, limitations, and prospects of large-scale application of different DNA diagnostics in China [51]. (The copyright permission of the Table 3 in the cited reference with modified form has been obtained from corresponding author of Professor Don McManus).
| Method Type | Advantages | Limitation | Instrument Cost * | Reagents Cost * | Prospect of Large-Scale Application ** |
|---|---|---|---|---|---|
| cPCR | Low cost and simple among the molecular detection methods; Can be multiplexed based on different size domains of the gene. | Requires post-PCR processing causing it to be more time consuming and labor intensive; | $ | $ | ∆ |
| nPCR | Improved the sensitivity and specificity for using two sets of primers | Relatively complicated initial optimization process; More time consuming and labor intensive than two rounds of cPCR amplifications; Prone to contamination with amplified PCR products | $ | $ | ∆ |
| qPCR | Higher sensitivity and specificity when probes are used; No post PCR processing and less time consuming and less labor intensive compared to cPCR and nPCR; Can quantify the amount of amplicons; Lower potential laboratory contamination | Relatively complicated initial optimization process; Requires triplicate reactions to improve the accuracy of final calculations | $$ | $ | ∆∆ |
| ddPCR | Higher sensitivity, specificity, specifically when probes are used; Can quantify the amount of amplicons (absolute quantification); Lower potential laboratory contamination | Requires specific and expensive machinery for the initial establishment; Relatively time consuming and complicated initial optimization process | $$$ | $$ | ∆ |
| LAMP | Less equipment required; Can visualize the end products directly using naked eye | Relatively time consuming and complicated initial optimization process; Prone to carryover contamination | - | $ | ∆∆∆ |
| RPA | Less equipment required; End products can be visualized on a chip/lateral flow device; Has great potential to be developed as a point of care diagnostic tool | Relatively complicated initial optimization process; Prone to contamination | - | $$$ | ∆∆ |
* The cost of the instrument and reagents is given as a relative scale to each other. Although the same conformity is used, the price of the instrument and reagents is not the same. $:—low, $$—moderate, $$$—high. ** It represents the possibility that it can be used as a tool for on-site screening and surveillance in the future: ∆—low, ∆∆—moderate, ∆∆∆—high.